PCM
ITCI

Prelude Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-79,142
Closed -$10.4M 1402
2025
Q1
$10.4M Buy
+79,142
New +$10.4M 0.79% 6
2024
Q2
Sell
-4,700
Closed -$325K 1464
2024
Q1
$325K Sell
4,700
-9,700
-67% -$671K 0.02% 765
2023
Q4
$1.03M Buy
14,400
+5,600
+64% +$401K 0.07% 252
2023
Q3
$458K Buy
8,800
+49
+0.6% +$2.55K 0.03% 405
2023
Q2
$554K Buy
8,751
+95
+1% +$6.02K 0.04% 363
2023
Q1
$469K Buy
8,656
+26
+0.3% +$1.41K 0.03% 427
2022
Q4
$457K Sell
8,630
-587
-6% -$31.1K 0.02% 534
2022
Q3
$429K Sell
9,217
-1,907
-17% -$88.8K 0.02% 696
2022
Q2
$635K Buy
11,124
+1,117
+11% +$63.8K 0.02% 574
2022
Q1
$612K Sell
10,007
-191
-2% -$11.7K 0.02% 598
2021
Q4
$534K Sell
10,198
-3,802
-27% -$199K 0.01% 742
2021
Q3
$522K Buy
14,000
+3,000
+27% +$112K 0.01% 649
2021
Q2
$449K Buy
+11,000
New +$449K 0.01% 805
2020
Q4
Hold
0
1671
2020
Q3
Hold
0
1948
2020
Q2
Hold
0
1771
2019
Q4
Hold
0
1838
2019
Q3
Hold
0
1666
2019
Q2
Sell
-5,318
Closed -$65K 1786
2019
Q1
$65K Buy
5,318
+4,889
+1,140% +$59.8K ﹤0.01% 738
2018
Q4
$5K Sell
429
-18,851
-98% -$220K ﹤0.01% 1273
2018
Q3
$418K Buy
19,280
+181
+0.9% +$3.92K 0.02% 377
2018
Q2
$337K Buy
19,099
+454
+2% +$8.01K 0.02% 501
2018
Q1
$392K Buy
18,645
+17,470
+1,487% +$367K 0.03% 440
2017
Q4
$17K Sell
1,175
-587
-33% -$8.49K ﹤0.01% 1028
2017
Q3
$28K Sell
1,762
-2,953
-63% -$46.9K ﹤0.01% 1135
2017
Q2
$59K Sell
4,715
-4,485
-49% -$56.1K 0.01% 862
2017
Q1
$150K Buy
+9,200
New +$150K 0.01% 618
2016
Q4
Sell
-28,136
Closed -$429K 1762
2016
Q3
$429K Buy
28,136
+21,567
+328% +$329K 0.05% 300
2016
Q2
$255K Sell
6,569
-1,070
-14% -$41.5K 0.04% 390
2016
Q1
$212K Buy
+7,639
New +$212K 0.03% 474